Faber, A. C., Coffee, E. M., Costa, C., Dastur, A., Ebi, H., Hata, A. N., . . . Engelman, J. A. (2013). mTOR Inhibition Specifically Sensitizes Colorectal Cancers with KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition by Suppressing MCL-1.
Styl ChicagoFaber, Anthony C., et al. MTOR Inhibition Specifically Sensitizes Colorectal Cancers With KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition By Suppressing MCL-1. 2013.
Citace podle MLAFaber, Anthony C., et al. MTOR Inhibition Specifically Sensitizes Colorectal Cancers With KRAS or BRAF Mutations to BCL-2/BCL-XL Inhibition By Suppressing MCL-1. 2013.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..